Grant: Travel Awards - Institute Community Support
Direct Payment
$1,000.00
Combined antisense downregulation of TS and IDO for better cancer treatment.
EF 2012-13
Résumé
With Canadian population aging cancer incidence is increasing every year. Traditional chemotherapy is still the main treatment option for most cancers. But it has two major drawbacks; side effects and rise of resistant tumours. Therefore, improving chemotherapy and reducing its side effects will have great impacts on cancer treatment. Cancer cells normally overproduce molecules that give them advantage of surviving bodies defensive mechanisms and chemotherapy. An example of the former is an enzyme called IDO and an example of the latter is another enzyme called TS. By targeting both IDO and TS messenger RNAs (mRNA) in cancer cells, I am hoping to improve bodies immune response and the chemotherapy's effects towards caner. By this approach, I will decrease the amount of chemotherapy drugs administered with gaining more effects, thus reducing the side effects of the drugs and increasing their efficiency.
Programme
Travel Awards - Institute Community Support
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
268715
Name
Maleki Saman
Region
Ontario
Country
Canada
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Institute of Cancer Research
Projecttitle
Combined antisense downregulation of TS and IDO for better cancer treatment.
Programtype2
Undefined
Orgnameinp2
Direct Payment
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Antisense; Cancer; Chemotherapy; Ido; Immune System; Ts
Abstract
With Canadian population aging cancer incidence is increasing every year. Traditional chemotherapy is still the main treatment option for most cancers. But it has two major drawbacks; side effects and rise of resistant tumours. Therefore, improving chemotherapy and reducing its side effects will have great impacts on cancer treatment. Cancer cells normally overproduce molecules that give them advantage of surviving bodies defensive mechanisms and chemotherapy. An example of the former is an enzyme called IDO and an example of the latter is another enzyme called TS. By targeting both IDO and TS messenger RNAs (mRNA) in cancer cells, I am hoping to improve bodies immune response and the chemotherapy's effects towards caner. By this approach, I will decrease the amount of chemotherapy drugs administered with gaining more effects, thus reducing the side effects of the drugs and increasing their efficiency.
Competitiondate
201209
Approvedterm2
0 yr 3 mths
Pinamesdelim
Maleki, Saman
Approvedterm
0 an 3 mois
Cihrcontribution2
Inst of Cancer Research~ $1,000~ $0~